Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2018 Filed May 8, 2020 17:03 UTC Amendment |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.99 Strike: $4.99 | $5,503.97 |
DisclosureSEC source: 0001445866-20-000586 · form4.xml · derivative · entry 19 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 8, 2020 17:03 UTC Amendment |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001445866-20-000586 · form4.xml · derivative · entry 18 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F14 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 8, 2020 15:15 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.98 Strike: $4.98 | $5,492.94 |
DisclosureSEC source: 0001445866-20-000584 · form4.xml · derivative · entry 12 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F12 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 8, 2020 15:15 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001445866-20-000584 · form4.xml · derivative · entry 11 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 8, 2020 14:21 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.99 Strike: $4.99 | $5,503.97 |
DisclosureSEC source: 0001445866-20-000582 · form4.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 8, 2020 14:21 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.99 Strike: $4.99 | $27,509.87 |
DisclosureSEC source: 0001445866-20-000582 · form4.xml · derivative · entry 7 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 8, 2020 14:15 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.99 Strike: $4.99 | $5,503.97 |
DisclosureSEC source: 0001445866-20-000580 · form4.xml · derivative · entry 17 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F17 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F17 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F17 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F17 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F17 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 8, 2020 14:15 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001445866-20-000580 · form4.xml · derivative · entry 16 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F16 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F16 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F16 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F16 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F16 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 3, 2020 22:58 UTC Amendment |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.99 Strike: $4.99 | $5,503.97 |
DisclosureSEC source: 0001445866-20-000811 · form4.xml · derivative · entry 15 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 3, 2020 22:58 UTC Amendment |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001445866-20-000811 · form4.xml · derivative · entry 14 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F14 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 3, 2020 22:22 UTC Amendment |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.99 Strike: $4.99 | $5,503.97 |
DisclosureSEC source: 0001445866-20-000809 · form4.xml · derivative · entry 17 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F17 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F17 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F17 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F17 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F17 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 3, 2020 22:22 UTC Amendment |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001445866-20-000809 · form4.xml · derivative · entry 16 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F16 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F16 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F16 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F16 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. F16 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 3, 2020 21:39 UTC Amendment |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.98 Strike: $4.98 | $5,492.94 |
DisclosureSEC source: 0001445866-20-000805 · form4.xml · derivative · entry 11 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 3, 2020 21:39 UTC Amendment |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001445866-20-000805 · form4.xml · derivative · entry 10 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 3, 2020 22:09 UTC Amendment |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.98 Strike: $4.98 | $5,492.94 |
DisclosureSEC source: 0001445866-20-000807 · form4.xml · derivative · entry 12 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F12 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 3, 2020 22:09 UTC Amendment |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001445866-20-000807 · form4.xml · derivative · entry 11 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 4, 2020 14:39 UTC Amendment |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.99 Strike: $4.99 | $5,503.97 |
DisclosureSEC source: 0001445866-20-000813 · form4.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 4, 2020 14:39 UTC Amendment |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.99 Strike: $4.99 | $27,509.87 |
DisclosureSEC source: 0001445866-20-000813 · form4.xml · derivative · entry 7 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 9, 2020 21:22 UTC |
Stephens Jeffrey RussellSr Gen Counsel/Corp Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,269 | $4.98 Strike: $4.98 | $41,179.62 |
DisclosureSEC source: 0001445866-20-000833 · primary_doc.xml · derivative · entry 9 Stephens Jeffrey Russell · CIK 0001488171 · Sr Gen Counsel/Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,269 Underlying: Class A Common Stock · 8,269 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · balance_after: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 9, 2020 19:27 UTC Amendment |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,050 | $4.98 Strike: $4.98 | $109,809.00 |
DisclosureSEC source: 0001445866-20-000830 · primary_doc.xml · derivative · entry 8 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,050 Underlying: Class C Common Stock · 22,050 shares Expires 2028-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · balance_after: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 9, 2020 17:57 UTC |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,050 | $4.98 Strike: $4.98 | $109,809.00 |
DisclosureSEC source: 0001445866-20-000828 · form4.xml · derivative · entry 8 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,050 Underlying: Class C Common Stock · 22,050 shares Expires 2028-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · balance_after: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 11, 2020 19:21 UTC |
Quist S. AndrewDirector · Vice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 27,563 | $4.98 Strike: $4.98 | $137,263.74 |
DisclosureSEC source: 0001445866-20-000838 · primary_doc.xml · derivative · entry 9 Quist S. Andrew · CIK 0001588309 · Director · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,563 Underlying: Class C Common Stock · 27,563 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · shares: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · balance_after: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 11, 2020 22:31 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.99 Strike: $4.99 | $5,503.97 |
DisclosureSEC source: 0001445866-20-000840 · form4.xml · derivative · entry 17 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 11, 2020 22:31 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001445866-20-000840 · form4.xml · derivative · entry 16 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F14 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 11, 2020 17:32 UTC |
QUIST SCOTT MDirector · Chairman of the Board/Pres/CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 77,175 | $5.48 Strike: $5.48 | $422,919.00 |
DisclosureSEC source: 0001445866-20-000837 · primary_doc.xml · derivative · entry 5 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board/Pres/CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,175 Underlying: Class A Common Stock · 77,175 shares Expires 2023-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F6 · shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F6 · price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F6 · balance_after: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Jun 12, 2020 20:05 UTC |
Overbaugh Jason G.Director · VP/Ntnl Marketing Dir-Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 27,563 | $4.98 Strike: $4.98 | $137,263.74 |
DisclosureSEC source: 0001445866-20-000844 · primary_doc.xml · derivative · entry 6 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,563 Underlying: Class C Common Stock · 27,563 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jun 12, 2020 18:55 UTC |
Quist Adam GeorgeVice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,050 | $4.98 Strike: $4.98 | $109,809.00 |
DisclosureSEC source: 0001445866-20-000843 · primary_doc.xml · derivative · entry 6 Quist Adam George · CIK 0001740330 · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,050 Underlying: Class C Common Stock · 22,050 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Jul 24, 2020 00:01 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001445866-20-001040 · primary_doc.xml · derivative · entry 16 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F16 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 24, 2020 00:01 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001445866-20-001040 · primary_doc.xml · derivative · entry 15 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 23, 2020 22:58 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001445866-20-001039 · primary_doc.xml · derivative · entry 18 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F18 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F18 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F18 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F18 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F18 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 23, 2020 22:58 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001445866-20-001039 · primary_doc.xml · derivative · entry 17 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F17 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F17 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F17 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F17 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F17 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 23, 2020 21:26 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001445866-20-001038 · primary_doc.xml · derivative · entry 9 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F9 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 23, 2020 21:26 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001445866-20-001038 · primary_doc.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 23, 2020 20:15 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001445866-20-001037 · primary_doc.xml · derivative · entry 13 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F13 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F13 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F13 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F13 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F13 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 23, 2020 20:15 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001445866-20-001037 · primary_doc.xml · derivative · entry 12 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F12 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 27, 2020 17:34 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001445866-20-001047 · form4.xml · derivative · entry 11 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 27, 2020 17:34 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001445866-20-001047 · form4.xml · derivative · entry 10 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 31, 2020 22:49 UTC |
Quist S. AndrewDirector · Vice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,252 | $4.86 Strike: $4.86 | $137,304.72 |
DisclosureSEC source: 0001445866-20-001099 · primary_doc.xml · derivative · entry 9 Quist S. Andrew · CIK 0001588309 · Director · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,252 Underlying: Class C Common Stock · 28,252 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F10 · shares: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F10 · price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F10 · balance_after: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 31, 2020 19:39 UTC |
Stephens Jeffrey RussellSr Gen Counsel/Corp Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,476 | $4.86 Strike: $4.86 | $41,193.36 |
DisclosureSEC source: 0001445866-20-001093 · primary_doc.xml · derivative · entry 9 Stephens Jeffrey Russell · CIK 0001488171 · Sr Gen Counsel/Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,476 Underlying: Class A Common Stock · 8,476 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2%stock dividend paid on July 17, 2020. F10 · shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2%stock dividend paid on July 17, 2020. F10 · price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2%stock dividend paid on July 17, 2020. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2%stock dividend paid on July 17, 2020. F10 · balance_after: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2%stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jul 31, 2020 18:25 UTC |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,601 | $4.86 Strike: $4.86 | $109,840.86 |
DisclosureSEC source: 0001445866-20-001091 · primary_doc.xml · derivative · entry 12 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,601 Underlying: Class C Common Stock · 22,601 shares Expires 2028-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F9 · balance_after: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Aug 3, 2020 21:29 UTC |
QUIST SCOTT MDirector · Chairman of the Board/Pres/CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 79,104 | $5.34 Strike: $5.34 | $422,415.36 |
DisclosureSEC source: 0001445866-20-001100 · primary_doc.xml · derivative · entry 5 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board/Pres/CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,104 Underlying: Class A Common Stock · 79,104 shares Expires 2023-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · balance_after: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Aug 6, 2020 22:33 UTC |
Overbaugh Jason G.Director · VP/Ntnl Marketing Dir-Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,252 | $4.86 Strike: $4.86 | $137,304.72 |
DisclosureSEC source: 0001445866-20-001119 · primary_doc.xml · derivative · entry 6 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,252 Underlying: Class C Common Stock · 28,252 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Aug 18, 2020 19:34 UTC |
Quist Adam GeorgeVice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,601 | $4.86 Strike: $4.86 | $109,840.86 |
DisclosureSEC source: 0001445866-20-001226 · primary_doc.xml · derivative · entry 6 Quist Adam George · CIK 0001740330 · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,601 Underlying: Class C Common Stock · 22,601 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Oct 8, 2020 22:44 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001445866-20-001512 · form4.xml · derivative · entry 13 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F12 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F12 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Oct 8, 2020 22:44 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001445866-20-001512 · form4.xml · derivative · entry 12 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Dec 3, 2020 19:53 UTC |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,601 | $4.86 Strike: $4.86 | $109,840.86 |
DisclosureSEC source: 0001096906-20-000421 · form4.xml · derivative · entry 6 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,601 Underlying: Class C Common Stock · 22,601 shares Expires 2028-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · balance_after: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Dec 9, 2020 16:30 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001096906-20-000452 · form4.xml · derivative · entry 9 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Dec 9, 2020 16:30 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001096906-20-000452 · form4.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Dec 19, 2020 00:22 UTC |
QUIST SCOTT MDirector · Chairman of the Board/Pres/CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 79,104 | $5.34 Strike: $5.34 | $422,415.36 |
DisclosureSEC source: 0001096906-20-000523 · form4.xml · derivative · entry 5 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board/Pres/CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,104 Underlying: Class A Common Stock · 79,104 shares Expires 2023-11-30 F5 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, and a 2 1/2% stock dividend paid on July 17, 2020. F5 · shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, and a 2 1/2% stock dividend paid on July 17, 2020. F5 · price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, and a 2 1/2% stock dividend paid on July 17, 2020. F5 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, and a 2 1/2% stock dividend paid on July 17, 2020. F5 · balance_after: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Dec 18, 2020 23:05 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001096906-20-000518 · form4.xml · derivative · entry 19 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F17 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F17 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F17 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F17 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F17 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.